A Case Report on Therapeutic Optimization and Cardiometabolic Benefits of Semaglutide Therapy in Type 2 Diabetes Mellitus: Case Report. JOPIR 2026, 4 (2), 252-258. https://doi.org/10.69613/ss2yp015.